Characterization of a preclinical model of simultaneous breast and ovarian cancer progression

Carcinogenesis

Volumn 28, Issue 1, 2007, Pages 130-135

  Ting, Alison Y ^a,b   Kimler, Bruce F ^a,b   Fabian, Carol J ^a,b   Petroff, Brian K ^a,b  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; DIMETHYLBENZ[A]ANTHRACENE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; KI 67 ANTIGEN; METHYLNITROSOUREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST ADENOCARCINOMA; BREAST CANCER; BREAST HYPERPLASIA; CANCER GROWTH; CANCER MODEL; CANCER RESEARCH; CARCINOMA IN SITU; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HISTOPATHOLOGY; MALIGNANT TRANSFORMATION; METASTASIS POTENTIAL; NONHUMAN; OVARY CANCER; OVARY CYST; OVARY HYPERTROPHY; PAGET NIPPLE DISEASE; PRECANCER; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT; SCORING SYSTEM;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ADENOCARCINOMA; ALKYLATING AGENTS; ANIMALS; CARCINOGENS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CELL PROLIFERATION; CELLS, CULTURED; COCARCINOGENESIS; CYCLOOXYGENASE 2; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EPITHELIUM; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FEMALE; HYPERPLASIA; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; MAMMARY NEOPLASMS, EXPERIMENTAL; METHYLNITROSOUREA; OVARIAN NEOPLASMS; PRECANCEROUS CONDITIONS; RATS; RATS, INBRED F344;

EID: 33845615541     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgl140     Document Type: Article

References (45)

1. Fabian,C.J., Kimler,B.F., Mayo,M.S. and Khan,S.A. (2005) Breast-tissue sampling for risk assessment and prevention. Endocr. Relat. Cancer, 12, 185-213.
2. Higgins,S.A., Matloff, E.T., Rimm,D.L., Dziura,J., Haffty,B.G. and King,B.L. (2005) Patterns of reduced nipple aspirate fluid production and ductal lavage cellularity in women at high risk for breast cancer. Breast Cancer Res., 7, R1017-R1022.
3. Khan,Q.J., Kimler,B.F., Clark,J., Metheny,T., Zalles,C.M. and Fabian,C.J. (2005) Ki-67 expression in benign breast ductal cells obtained by random periareolar fine needle aspiration. Cancer Epidemiol. Biomarkers Prev., 14, 786-789.
4. Gershenson,D.M., Tortolero-Luna,G., Malpica,A., Baker,V.V., Whittaker,L., Johnson,E. and Follen Mitchell,M. (1996) Ovarian intraepithelial neoplasia and ovarian cancer. Obstet. Gynecol. Clin. North Am., 23, 475-543.
5. De Palo,G., Mariani,L., Camerini,T., Marubini,E., Formelli,F., Pasini,B., Decensi,A. and Veronesi,U. (2002) Effect of fenretinide on ovarian carcinoma occurrence. Gynecol. Oncol., 86, 24-27.
6. Thompson,H.J., McGinley,J.N., Rothhammer,K. and Singh,M. (1995) Rapid induction of mammary intraductal proliferations, ductal carcinoma in situ and carcinomas by the injection of sexually immature female rats with 1-methyl-1-nitrosourea. Carcinogenesis, 16, 2407-2411.
7. Swanson,S.M. and Unterman,T.G. (2002) The growth hormone-deficient spontaneous dwarf rat is resistant to chemically induced mammary carcinogenesis. Carcinogenesis, 23, 977-982.
8. Li,J.J., Papa,D., Davis,M.F., Weroha,S.J., Aldaz,C.M., El-Bayoumy,K., Ballenger,J., Tawfik,O. and Li,S.A. (2002) Ploidy differences between hormone- and chemical carcinogen-induced rat mammary neoplasms: comparison to invasive human ductal breast cancer. Mol. Carcinog., 33, 56-65.
9. Nishida,T., Sugiyama,T., Kataoka,A., Ushijima,K. and Yakushiji,M. (1998) Histologic characterization of rat ovarian carcinoma induced by intraovarian insertion of a 7,12-dimethylbenz[α]anthracene-coated suture: Common epithelial tumors of the ovary in rats? Cancer, 83, 965-970.
10. Stewart,S.L., Querec,T.D., Ochman,A.R. et al. (2004) Characterization of a carcinogenesis rat model of ovarian preneoplasia and neoplasia. Cancer Res., 64, 8177-8183.
11. Crist,K.A., Zhang,Z., You,M., Gunning,W.T., Conran,P.B., Steele,V.E. and Lubet,R.A. (2005) Characterization of rat ovarian adenocarcinomas developed in response to direct instillation of 7,12-dimethylbenz[α]-anthracene (DMBA) coated suture. Carcinogenesis, 26, 951-957.
12. Anzalone,C.R., Hong,L.S., Lu,J.K. and LaPolt,P.S. (2001) Influences of age and ovarian follicular reserve on estrous cycle patterns, ovulation, and hormone secretion in the Long-Evans rat. Biol. Reprod., 64, 1056-1062.
13. Chatterjee,A. and Greenwald,G.S. (1972) The long-term effects of unilateral ovariectomy of the cycling hamster and rat. Biol. Reprod., 7, 238-246.
14. Cotroneo,M.S., Wang,J., Fritz,W.A., Eltoum,I.E. and Lamartiniere,C.A. (2002) Genistein action in the prepubertal mammary gland in a chemoprevention model. Carcinogenesis, 23, 1467-1474.
15. Thompson,H.J. and Singh,M. (2000) Rat models of premalignant breast disease. J. Mammary Gland Biol. Neoplasia, 5, 409-420.
16. Tawfik,O.W., Kimler,B.F., Davis,M. et al. (2006) Comparison of immunohistochemistry by automated cellular imaging system (ACIS) versus fluorescence in-situ hybridization in the evaluation of HER-2/neu expression in primary breast carcinoma. Histopathology, 48, 258-267.
17. Martin,A.M. and Weber,B.L. (2000) Genetic and hormonal risk factors in breast cancer. J. Natl. Cancer Inst., 92, 1126-1135.
18. Antoniou,A.C., Gayther,S.A., Stratton,J.F., Ponder,B.A. and Easton,D.F. (2000) Risk models for familial ovarian and breast cancer. Genet. Epidemiol., 18, 173-190.
19. Syed,V., Ulinski,G., Mok,S.C., Yiu,G.K. and Ho,S.M. (2001) Expression of gonadotropin receptor and growth responses to key reproductive hormones in normal and malignant human ovarian surface epithelial cells. Cancer Res., 61, 6768-6776.
20. Scully,R.E. (1995) Pathology of ovarian cancer precursors. J. Cell. Biochem. Suppl., 23, 208-218.
21. Feeley,K.M. and Wells,M. (2001) Precursor lesions of ovarian epithelial malignancy. Histopathology, 38, 87-95.
22. Brewer,M.A., Ranger-Moore,J., Greene,M.H., Alberts,D.S., Liu,Y., Bartels,H.G., Baruch,A.C. and Bartels,P.H. (2004) Preneoplastic changes in ovarian tissues. Anal. Quant. Cytol. Histol., 26, 207-216.
23. Mittal,K.R., Zeleniuch-Jacquotte,A., Cooper,J.L. and Demopoulos,R.I. (1993) Contralateral ovary in unilateral ovarian carcinoma: A search for preneoplastic lesions. Int. J. Gynecol. Pathol., 12, 59-63.
24. Resta,L., Russo,S., Colucci,G.A. and Prat,J. (1993) Morphologic precursors of ovarian epithelial tumors. Obstet. Gynecol., 82, 181-186.
25. Werness,B.A., Afify,A.M., Bielat,K.L., Eltabbakh,G.H., Piver,M.S. and Paterson,J.M. (1999) Altered surface and cyst epithelium of ovaries removed prophylactically from women with a family history of ovarian cancer. Hum. Pathol., 30, 151-157.
26. Okamura,H. and Katabuchi,H. (2001) Detailed morphology of human ovarian surface epithelium focusing on its metaplastic and neoplastic capability. Ital. J. Anat. Embryol., 106, 263-276.
27. Singhal,P.K., Spiegel,G., Driscoll,D., Odunsi,K., Lele,S. and Rodabaugh,K.J. (2005) Cyclooxygenase 2 expression in serous tumors of the ovary. Int. J. Gynecol. Pathol., 24, 62-66.
28. Matsumoto,Y., Ishiko,O., Deguchi,M., Nakagawa,E. and Ogita,S. (2001) Cyclooxygenase-2 expression in normal ovaries and epithelial ovarian neoplasms. Int. J. Mol. Med., 8, 31-36.
29. Denkert,C., Kobel,M., Pest,S., Koch,I., Berger,S., Schwabe,M., Siegert,A., Reles,A., Klosterhalfen,B. and Hauptmann,S. (2002) Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinoma. Am. J. Pathol., 160, 893-903.
30. Shigemasa,K., Tian,X., Gu,L., Shiroyama,Y., Nagai,N. and Ohama,K. (2003) Expression of cyclooxygenase-2 and its relationship to p53 accumulation in ovarian adenocarcinomas. Int. J. Oncol., 22, 99-105.
31. Roland,I.H., Yang,W.L., Yang,D.H., Daly,M.B., Ozols,R.F., Hamilton,T.C., Lynch,H.T., Godwin,A.K. and Xu,X.X. (2003) Loss of surface and cyst epithelial basement membranes and preneoplastic morphologic changes in prophylactic oophorectomies. Cancer, 98, 2607-2623.
32. Daikoku,T., Tranguch,S., Trofimova,I.N., Dinulescu,D.M., Jacks,T., Nikitin,A.Y., Connolly,D.C. and Dey,S.K. (2006) Cyclooxygenase-1 is overexpressed in multiple genetically engineered mouse models of epithelial ovarian cancer. Cancer Res., 66, 2527-2531.
33. Li,S., Miner,K., Fannin,R., Carl Barrett,J. and Davis,B.J. (2004) Cyclooxygenase-1 and 2 in normal and malignant human ovarian epithelium. Gynecol. Oncol., 92, 622-627.
34. Turan,V.K., Sanchez,R.I., Li,J.J., Li,S.A., Reuhl,K.R., Thomas,P.E., Conney,A.H., Gallo,M.A., Kauffman,F.C. and Mesia-Vela,S. (2004) The effects of steroidal estrogens in ACI rat mammary carcinogenesis: 17beta-estradiol, 2-hydroxyestradiol, 4-hydroxyestradiol, 16alpha-hydroxyestradiol, and 4-hydroxyestrone. J. Endocrinol., 183, 91-99.
35. Li,S.A., Weroha,S.J., Tawfik,O. and Li,J.J. (2002) Prevention of solely estrogen-induced mammary tumors in female aci rats by tamoxifen: evidence for estrogen receptor mediation. J. Endocrinol., 175, 297-305.
36. Thompson,H.J. and Adlakha,H. (1991) Dose-responsive induction of mammary gland carcinomas by the intraperitoneal injection of 1-methyl-nitrosourea. Cancer Res., 51, 3411-3415.
37. Jang,T.J., Jung,H.G., Jung,K.H. and O,M.K. (2002) Chemopreventive effect of celecoxib and expression of cyclooxygenase-1 and cyclooxygenase-2 on chemically-induced rat mammary tumours. Int. J. Exp. Pathol., 83, 173-182.
38. Dao,T.L. (1962) The role of ovarian hormones in initiating the induction of mammary cancer in rats by polynuclear hydrocarbons. Cancer Res., 22, 973-981.
39. Murdoch,W.J. and McDonnel,A.C. (2002) Roles of the ovarian surface epithelium in ovulation and carcinogenesis. Reproduction, 123, 743-750.
40. Dietl,J. and Marzusch,K. (1993) Ovarian surface epithelium and human ovarian cancer. Gynecol. Obstet. Invest., 35, 129-135.
41. Fabian,C.J., Kimler,B.F., Anderson,J. et al. (2004) Breast cancer chemoprevention phase I evaluation of biomarker modulation by arzoxifene, a third generation selective estrogen receptor modulator. Clin. Cancer Res., 10, 5403-5417.
42. Liang,Y. and Hyder,S.M. (2005) Proliferation of endothelial and tumor epithelial cells by progestin-induced vascular endothelial growth factor from human breast cancer cells: Paracrine and autocrine effects. Endocrinology, 146, 3632-3641.
43. Bu,S.Z., Yin,D.L., Ren,X.H., Jiang,L.Z., Wu,Z.J., Gao,Q.R. and Pei,G. (1997) Progesterone induces apoptosis and up-regulation of p53 expression in human ovarian carcinoma cell lines. Cancer, 79, 1944-1950.
44. Ivarsson,K., Sundfeldt,K., Brannstrom,M. and Janson,P.O. (2001) Production of steroids by human ovarian surface epithelial cells in culture: Possible role of progesterone as growth inhibitor. Gynecol. Oncol., 82, 116-121.
45. Jabara,A.G. and Harcourt,A.G. (1971) Effects of progesterone, ovariectomy and adrenalectomy on mammary tumours induced by 7,12-dimethylbenz (α)anthracene in Sprague-Dawley rats. Pathology, 3, 209-214.